883.68
1.79%
+15.58
Dopo l'orario di chiusura:
886.00
2.32
+0.26%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LRCX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$868.10
Aprire:
$881.04
Volume 24 ore:
698.84K
Capitalizzazione di mercato:
$115.53B
Reddito:
$14.24B
Utile/perdita netta:
$3.61B
Rapporto P/E:
30.05
EPS:
29.41
Flusso di cassa netto:
$4.54B
1 W Prestazione:
-1.97%
1M Prestazione:
-8.65%
6M Prestazione:
+41.78%
1 anno Prestazione:
+69.33%
Lam Research Corp. Stock (LRCX) Company Profile
Nome
Lam Research Corp.
Settore
Industria
Telefono
510-572-0200
Indirizzo
4650 Cushing Parkway, Fremont, CA
Lam Research Corp. Stock (LRCX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-01-25 | Reiterato | TD Cowen | Outperform |
2024-01-23 | Iniziato | Cantor Fitzgerald | Neutral |
2023-12-12 | Downgrade | Deutsche Bank | Buy → Hold |
2023-12-08 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2023-11-22 | Iniziato | Redburn Atlantic | Buy |
2023-10-17 | Iniziato | Raymond James | Outperform |
2023-10-13 | Aggiornamento | Needham | Hold → Buy |
2023-09-15 | Iniziato | Wolfe Research | Outperform |
2023-07-24 | Reiterato | Mizuho | Buy |
2023-07-24 | Aggiornamento | Stifel | Hold → Buy |
2023-04-20 | Reiterato | Berenberg | Buy |
2023-04-20 | Reiterato | Evercore ISI | Outperform |
2023-04-20 | Reiterato | JP Morgan | Overweight |
2023-04-20 | Reiterato | Jefferies | Buy |
2023-04-20 | Reiterato | Mizuho | Buy |
2023-04-20 | Reiterato | Stifel | Hold |
2023-04-20 | Reiterato | Wells Fargo | Equal Weight |
2023-03-13 | Downgrade | Bernstein | Outperform → Mkt Perform |
2023-01-18 | Ripresa | Stifel | Hold |
2022-12-12 | Aggiornamento | Deutsche Bank | Hold → Buy |
2022-10-20 | Reiterato | B. Riley Securities | Neutral |
2022-10-20 | Reiterato | BofA Securities | Buy |
2022-10-20 | Reiterato | DA Davidson | Neutral |
2022-10-20 | Reiterato | Evercore ISI | Outperform |
2022-10-20 | Reiterato | JP Morgan | Overweight |
2022-10-20 | Reiterato | Jefferies | Buy |
2022-10-20 | Aggiornamento | Summit Insights | Hold → Buy |
2022-10-20 | Reiterato | Wells Fargo | Equal Weight |
2022-07-25 | Downgrade | Barclays | Overweight → Equal Weight |
2022-06-15 | Downgrade | B. Riley Securities | Buy → Neutral |
2022-01-27 | Reiterato | Barclays | Overweight |
2022-01-27 | Reiterato | Deutsche Bank | Hold |
2022-01-27 | Reiterato | Evercore ISI | Outperform |
2022-01-27 | Reiterato | Stifel | Buy |
2022-01-27 | Reiterato | Susquehanna | Neutral |
2022-01-27 | Reiterato | UBS | Buy |
2022-01-26 | Iniziato | KeyBanc Capital Markets | Sector Weight |
2022-01-12 | Reiterato | Barclays | Overweight |
2022-01-10 | Reiterato | BofA Securities | Buy |
2022-01-05 | Ripresa | Jefferies | Buy |
2021-12-15 | Reiterato | Deutsche Bank | Hold |
2021-10-21 | Reiterato | B. Riley Securities | Buy |
2021-10-21 | Downgrade | Summit Insights | Buy → Hold |
2021-10-15 | Iniziato | Piper Sandler | Neutral |
2021-09-14 | Downgrade | Susquehanna | Positive → Neutral |
2021-09-07 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
2021-07-29 | Reiterato | Mizuho | Buy |
2021-07-29 | Reiterato | Stifel | Buy |
2021-07-29 | Reiterato | UBS | Buy |
2021-07-29 | Reiterato | Wells Fargo | Equal Weight |
2021-03-31 | Iniziato | Bernstein | Outperform |
2021-01-28 | Reiterato | Cowen | Outperform |
2021-01-08 | Downgrade | Needham | Buy → Hold |
2020-12-17 | Downgrade | Deutsche Bank | Buy → Hold |
2020-10-22 | Reiterato | Goldman | Buy |
2020-10-22 | Reiterato | KeyBanc Capital Markets | Overweight |
2020-10-22 | Reiterato | Mizuho | Buy |
2020-10-22 | Reiterato | Morgan Stanley | Overweight |
2020-10-22 | Reiterato | RBC Capital Mkts | Outperform |
2020-10-22 | Reiterato | Stifel | Buy |
2020-10-22 | Reiterato | UBS | Buy |
2020-09-21 | Aggiornamento | Stifel | Hold → Buy |
2020-07-30 | Reiterato | Cowen | Outperform |
2020-07-21 | Aggiornamento | B. Riley FBR | Neutral → Buy |
2020-06-22 | Downgrade | Stifel | Buy → Hold |
2020-06-16 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2020-05-26 | Iniziato | Barclays | Overweight |
2020-04-23 | Reiterato | Needham | Buy |
2020-04-08 | Iniziato | Exane BNP Paribas | Outperform |
2020-04-03 | Aggiornamento | Nomura | Neutral → Buy |
2020-04-02 | Downgrade | DA Davidson | Buy → Neutral |
2020-03-27 | Aggiornamento | Deutsche Bank | Hold → Buy |
2020-03-27 | Aggiornamento | UBS | Sell → Buy |
Mostra tutto
Lam Research Corp. Borsa (LRCX) Ultime notizie
Here is What to Know Beyond Why Lam Research Corporation (LRCX) is a Trending Stock
Zacks Investment Research
Unlocking Lam Research (LRCX) International Revenues: Trends, Surprises, and Prospects
Zacks Investment Research
Top Tech Stocks Moving Higher After Earnings
Zacks Investment Research
Lam Research Expects 2024 To Be A 'Transition Year,' 4 Analysts Provide Key Q3 Takeaways
Benzinga
Stocks Drop, Tech Tumbles With Meta's Weak Outlook, Q1 Stagflation Fears; Gold Miners Advance: What's Driving Markets Thursday?
Benzinga
Lam Research (LRCX) Q3 Earnings Beat, Revenues Decline Y/Y
Zacks Investment Research
Lam Research Corp. Azioni (LRCX) Dati Finanziari
Lam Research Corp. (LRCX) Reddito 2024
LRCX ha riportato un ricavo (TTM) di $14.24 miliardi per il trimestre terminato il 2024-03-31, un -24.48% declino anno su anno.
Lam Research Corp. (LRCX) Reddito netto 2024
LRCX l'utile netto (TTM) è stato di $3.61 miliardi per il trimestre terminato il 2024-03-31, un -26.59% diminuire anno su anno.
Lam Research Corp. (LRCX) Flusso di cassa 2024
LRCX ha registrato un flusso di cassa disponibile (TTM) di $4.54 miliardi per il trimestre conclusosi con 2024-03-31, un +14.84% aumento anno su anno.
Lam Research Corp. (LRCX) Utile per azione 2024
L'utile per azione (TTM) di LRCX è stato pari a $27.19 per il trimestre terminato il 2024-03-31, un -24.28% declino anno su anno.
Lam Research Corp. Azioni (LRCX) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
TALWALKAR ABHIJIT Y | Director |
Apr 01 '24 |
Sale |
972.03 |
882 |
857,330 |
10,541 |
Corrreia Christina | CVP , Chief Accounting Officer |
Apr 01 '24 |
Sale |
972.03 |
647 |
628,903 |
5,541 |
Varadarajan Seshasayee | Senior Vice President |
Mar 19 '24 |
Sale |
913.99 |
5,500 |
5,026,945 |
16,595 |
Varadarajan Seshasayee | Senior Vice President |
Mar 18 '24 |
Sale |
922.41 |
5,500 |
5,073,255 |
22,095 |
LORD PATRICK J | Executive Vice President |
Mar 11 '24 |
Option Exercise |
542.54 |
4,795 |
2,601,498 |
9,992 |
LORD PATRICK J | Executive Vice President |
Mar 11 '24 |
Sale |
927.90 |
4,795 |
4,449,265 |
7,966 |
LORD PATRICK J | Executive Vice President |
Mar 11 '24 |
Sale |
927.79 |
3,452 |
3,202,737 |
4,514 |
ARCHER TIMOTHY | President and CEO |
Feb 07 '24 |
Option Exercise |
0.00 |
11,990 |
0 |
98,439 |
Bettinger Douglas R | Chief Financial Officer & EVP |
Feb 06 '24 |
Option Exercise |
0.00 |
3,324 |
0 |
100,037 |
LORD PATRICK J | Executive Vice President |
Feb 06 '24 |
Option Exercise |
0.00 |
2,724 |
0 |
8,925 |
Capitalizzazione:
|
Volume (24 ore):